Results 41 to 50 of about 109,033 (289)

5-year results of a newly implemented mechanical circulatory support program for terminal heart failure patients in a Swiss non-cardiac transplant university hospital

Journal of Cardiothoracic Surgery, 2021
Background In Switzerland, long-term circulatory support programs have been limited to heart transplant centers. In 2014, to improve the management of patients with end-stage heart failure not eligible for transplantation, we implemented a left ...
Thibault Schaeffer, Otmar Pfister, Constantin Mork, Paul Mohacsi, Florian Rueter, Simon Scheifele, Anne Morgen, Urs Zenklusen, Thomas Doebele, Markus Maurer, Joachim Erb, Jens Fassl, Nadine Cueni, Martin Siegemund, Hans Pargger, Brigitta Gahl, Stefan Osswald, Friedrich Eckstein, Martin Grapow   +18 more
doaj   +1 more source

LVAD pannus complicating destination therapy

Human Pathology: Case Reports, 2017
Despite advances in technology, ventricular assist devices still experience a number of complications limiting their long-term use. We present a 73-year-old woman implanted with a left ventricular assist device (LVAD) five years prior due to end-stage ...
Maya Ignaszewski, Margaret Robin B. Cases, Davide Salina, Elizabeth Swiggum, Anson Cheung, Andrew P. Ignaszewski, Michael A. Seidman   +6 more
doaj   +1 more source

35. With full antiplatelet and anticoagulant coverage: Still aortic root and left main coronary artery thrombosis can occur early post left ventricular assist device implantation

Journal of the Saudi Heart Association, 2016
We describe a case of 39 years old male underwent continuous flow LVAD implantation (HeartWare) HVAD as destination therapy (DT) for severe left ventricular dysfunction ,moderate right ventricular dysfunction and severe pulmonary hypertension , presented
M. alassal
doaj   +1 more source

End-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die?

BMC Medical Ethics, 2010
Background Bioethics and law distinguish between the practices of "physician-assisted death" and "allowing the patient to die." Discussion Advances in biotechnology have allowed medical devices to be used as destination therapy that are designed for the ...
Rady Mohamed Y, Verheijde Joseph L
doaj   +1 more source

Heart failure risk scores in advanced heart failure patients: insights from the LEVO‐D registry

ESC Heart Failure, 2023
Aims The prevalence of advanced heart failure (HF) is increasing due to the growing number of patients with HF and their better treatment and survival.
Pau Codina, David Dobarro, Javier deJuan‐Bagudá, Fernando De Frutos, Josep Lupón, Antoni Bayes‐Genis, José Gonzalez‐Costello, Spanish LEVO‐D registry Collaborators   +7 more
doaj   +1 more source

Mechanical Ventricular Assistance as Destination Therapy for End-Stage Heart Failure: Has it become a first line therapy?

Frontiers in Surgery, 2015
Patients with end-stage heart failure have poor quality of life and prognosis.Therapeutic options are scarce and not available for all:only few patients can be transplanted and several medical and surgical strategies have shown limited ability to ...
Massimo eBonacchi, Guy eHarmelin, Marco eBugetti, Guido eSani   +3 more
doaj   +1 more source

What Should We Learn From Early Hemodialysis Allocation About How We Should Be Using ECMO? [PDF]

, 2019
Early hemodialysis allocation deliberations should inform our current considerations of what constitutes reasonable uses of extracorporeal membrane oxygenation.
bosslet, Gabriel T., Gutteridge, Daniel
core   +1 more source

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients The ROADMAP Study 2-Year Results [PDF]

, 2017
OBJECTIVES The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years ...
Boyle, Andrew J., Bruckner, Brian A., Chuang, Joyce, Estep, Jerry D., Farrar, David J., Haas, Donald C., Horstmanshof, Douglas A., Kasirajan, Vigneshwar, Lee, Sangjin, Long, James W., Milano, Carmelo A., Rogers, Joseph G., Selzman, Craig H., Shah, Keyur B., Starling, Randall C., Stehlik, Josef   +15 more
core   +2 more sources

Hypoxia in the Initiation and Progression of Neuroblastoma Tumours [PDF]

, 2020
Neuroblastoma is the most frequent extracranial solid tumour in children, causing 10% of all paediatric oncology deaths. It arises in the embryonic neural crest due to an uncontrolled behaviour of sympathetic nervous system progenitors, giving rise to ...
Gómez Muñoz, María Ángeles, Huertas Castaño, Carlos, Pardal Redondo, Ricardo, Vega Moreno, Francisco Manuel   +3 more
core   +1 more source

Ethical challenges with the left ventricular assist device as a destination therapy

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +1 more source